Montelukast as add-on therapy to inhaled corticosteroids in the management of asthma (the SAS trial)

AIM: To evaluate the effectiveness of montelukast as add-on therapy for asthmatic patients who remain uncontrolled with low, moderate or high doses of inhaled corticosteroid monotherapy. DESIGN: An eight-week, multicentre, open-label, observational study. RESULTS: Of 320 patients enrolled, 288 (90.0...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: FitzGerald, J Mark, Foucart, Sylvain, Coyle, Stephen, Sampalis, John, Haine, Denis, Psaradellis, Eliofotisti, McIvor, R Andrew
Format: Artigo
Idioma:Inglês
Publicat: Pulsus Group Inc 2009
Matèries:
Asthma Care in Canada
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3486710/
https://ncbi.nlm.nih.gov/pubmed/19557206
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars